MARKET

AKTS

AKTS

AKTIS ONCOLOGY INC
NASDAQ
19.49
-0.24
-1.22%
Opening 10:45 05/13 EDT
OPEN
19.47
PREV CLOSE
19.73
HIGH
19.65
LOW
19.22
VOLUME
22.41K
TURNOVER
--
52 WEEK HIGH
29.16
52 WEEK LOW
14.72
MARKET CAP
1.08B
P/E (TTM)
-15.4892
1D
5D
1M
3M
1Y
5Y
1D
Aktis Oncology Initiated at Buy on Differentiated Radiopharmaceutical Platform and Multiple High-Value Oncology Targets
TipRanks · 1d ago
Bank of America Securities Reaffirms Their Buy Rating on Aktis Oncology, Inc. (AKTS)
TipRanks · 1d ago
Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Metagenomi, Inc. (MGX)
TipRanks · 1d ago
Aktis Oncology reports Q1 revenue $3.23M, consensus $1.85M
TipRanks · 1d ago
Aktis Oncology, Inc. reports Q1 results
Seeking Alpha · 1d ago
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Reuters · 1d ago
Aktis Oncology Q1 FY26 net loss widens to $18.3 million; revenue climbs to $3.2 million
PUBT · 1d ago
*Aktis Oncology 1Q Rev $3.23M >AKTS
Dow Jones · 1d ago
More
About AKTS
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.

Webull offers Aktis Oncology, Inc. stock information, including NASDAQ: AKTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKTS stock methods without spending real money on the virtual paper trading platform.